Shanghai Pharma's Industrial Segment Encompasses a Broad Spectrum of Pharmaceutical and Healthcare Products

Deep News05-27

In response to inquiries from researchers, Shanghai Pharmaceuticals Holding Co., Ltd. indicated that its industrial segment covers a wide range of areas including chemical and biological drugs, modern traditional Chinese medicines and health supplements, as well as medical devices. The company focuses on disease areas such as immunology, neuropsychiatry, oncology, cardiovascular, digestive and metabolic disorders, and anti-infectives. It operates pharmaceutical production bases across 12 provinces and municipalities in China and overseas, consistently manufacturing approximately 800 drug specifications across more than 30 dosage forms. In 2025, the company had 40 products with industrial sales exceeding 100 million yuan, including four products with sales surpassing 1 billion yuan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment